• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非特异性抗肿瘤抵抗力的评估标准]

[Criteria for evaluation of non-specific anti-tumor resistance].

作者信息

Sheĭko E A, Pil' E A

出版信息

Vopr Onkol. 1994;40(4-6):211-5.

PMID:7785247
Abstract

Non-specific antitumor resistance levels have been measured by correlation-regression analysis on the basis of 33 parameters in rats with tumors and under the influence of Thio-TEPA treatment, endolymphatic administration included. The study established 16 highly-informative criteria and parameter a, an integral indicator for non-specific antitumor resistance evaluation, which describes the synthetic activity of peripheral blood lymphocytes.

摘要

通过对荷瘤大鼠以及在硫替派治疗(包括内淋巴给药)影响下的33个参数进行相关回归分析,测定了非特异性抗肿瘤抵抗力水平。该研究确定了16个高信息量标准以及参数a,参数a是用于评估非特异性抗肿瘤抵抗力的综合指标,它描述了外周血淋巴细胞的综合活性。

相似文献

1
[Criteria for evaluation of non-specific anti-tumor resistance].[非特异性抗肿瘤抵抗力的评估标准]
Vopr Onkol. 1994;40(4-6):211-5.
2
[Coordination of lymphocytic enzymes of the rat thymus gland in experimental chemotherapy].[实验化疗中大鼠胸腺淋巴细胞酶的协调作用]
Vopr Onkol. 1994;40(4-6):207-10.
3
[Chromosomal aberrations induced by thio-TEPA in cells of malignant ovarian tumors in humans].[硫代替派诱导人恶性卵巢肿瘤细胞中的染色体畸变]
Vopr Onkol. 1975;21(7):48-53.
4
[Preoperative chemotherapy of malignant ovarian neoplasms].[恶性卵巢肿瘤的术前化疗]
Vopr Onkol. 1973;19(2):20-3.
5
[A cytogenetic analysis of variants of a strain of rat ovary tumors resistant to 6-mercaptopurine and thio-TEPA].[对一株对6-巯基嘌呤和硫代三乙烯磷酰胺耐药的大鼠卵巢肿瘤变异株的细胞遗传学分析]
Vopr Onkol. 1970 May;16(5):87-92.
6
[Changes in the functional state of the liver following endolymphatic administration of massive doses of thio-TEPA to patients with cancer of the uterine cervix].[对子宫颈癌患者进行大剂量硫替派内淋巴给药后肝脏功能状态的变化]
Pediatr Akus Ginekol. 1972 May-Jun;3:56-8.
7
Thio-TEPA and methotrexate chemotherapy of advanced ovarian carcinoma.
J Mt Sinai Hosp N Y. 1968 Jan-Feb;35(1):52-67.
8
[Activity of enzymes of intermediate protein metabolism in thio-TEPA treatment of patients with ovarian cancer].[硫代替派治疗卵巢癌患者时中间蛋白质代谢酶的活性]
Vopr Onkol. 1974 Oct;20(7):96-7.
9
Thio-tepa chemotherapy for ovarian carcinoma. Influence of remission and toxicity on survival.
Obstet Gynecol. 1970 Feb;35(2):278-86.
10
Treatment of ovarian cancer with thiotepa.噻替派治疗卵巢癌
Clin Obstet Gynecol. 1968 Jun;11(2):428-38.